QUOTE AND NEWS
TheStreet.com  Apr 9  Comment 
NEW YORK (TheStreet) -- Senomyx was gaining 8.2% to $11.05 following the announcement of a new partnership with PepsiCo . Under the new partnership Pepsi will fund Senomyx's Salt Taste Program for 2014. Pepsi will gain non-exclusive rights to...
StreetInsider.com  Apr 9  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Senomyx+%28SNMX%29+Gains+After+Enters+Into+Research+Agreement+With+PepsiCo/9365572.html for the full story.
SeekingAlpha  Mar 13  Comment 
Senomyx Inc (SNMX) Q4 2013 Results Conference Call March 13, 2014 / 11:00 A.M. E.T. Executives Gwen Rosenberg – VP of IR & Corporate Communications John Poyhonen – CEO Sharon Wicker – SVP & Chief Commercial Development...
TheStreet.com  Mar 13  Comment 
NEW YORK (TheStreet) -- Senomyx  is tumbling on Thursday after posting below-consensus financials in its fourth quarter. By late afternoon, shares had taken off 5.4% to $10.56. Trading volume of 1.2 million was nearly double its three-month...
StreetInsider.com  Mar 13  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Senomyx%2C+Inc.+%28SNMX%29+Posts+Q4+Loss+of+8cShare%3B+Issues+Light+FY14+Outlook/9277524.html for the full story.
SeekingAlpha  Mar 12  Comment 
By Stephen Simpson, CFA: Patience with development-stage food additive developer Senomyx (SNMX) has really started paying off over the last six months. Investors started bidding up the shares on expectations of FDA approval of key product S617, as...
StreetInsider.com  Mar 11  Comment 
52-Week High: Capstone Turbine Corp. (Nasdaq: CPST) $2.42. Capstone momentum continues as fuell cell peers making even more gains. Earlier, Cowen boosted its price target on the company to $2.70, citing several key upcoming catalysts through...
TheStreet.com  Mar 11  Comment 
NEW YORK (TheStreet) -- Senomyx  is spiking on Tuesday after its Sweetmyx food flavoring was found to be safe. By midday, shares had added 25.2% to $11.78. San Diego-based Senomyx, which develops food and beverage flavorings, said its Sweetmyx...
Benzinga  Mar 11  Comment 
Senomyx (NASDAQ: SNMX) shares moved up 18.92% to $11.19. The volume of Senomyx shares traded was 968% higher than normal. SENOMYX reported the receipt of Generally Recognized as Safe (GRAS) determination for new Sweetmyx™ flavor...




 
TOP CONTRIBUTORS

Senomyx, Inc. was founded September 1998 by Howard Hughes Medical Investigators Charles Zuker and Roger Y. Tsien (Nobel Laureate), whom also founded Aurora Biosciences (acquired by Vertex Pharmaceuticals for about $592 million in stock). Senomyx uses taste receptor-based assays and screening technologies to discover and develop flavor enhancers and taste modulators for the food and beverage industry. The Company has entered into development collaborations with seven leading food, beverage, and ingredient supply companies, which include Ajinomoto Co., Inc., Cadbury Schweppes, Campbell Soup Company, The Coca-Cola Company, Firmenich SA, Nestle SA and Solae LLC.

Senomyx’s current focus programs include the discovery and development of 1) savory, sweet, and salt flavor ingredients that can substitute or allow for the reduction of MSG, sugar, and salt in food and beverage products, 2) bitter blockers that will reduce or block bitter tastes in foods, beverages, and pharmaceuticals, and 3) cooling ingredients for a cooling taste effect for confectioneries, foods and beverages, and oral care and OTC healthcare products.

References

Xu, H., Staszewski, L., Tang, H., Adler, E., Zoller, M., and Li, X. (2004). Different functional roles of T1R subunits in the heteromeric taste receptors. Proc. Natl. Acad. Sci. USA, 101:14258-14263.

Li, X., Staszewski, L., Xu, H., Durick, K., Zoller, M., Adler, E. (2002). Human receptors for sweet and umami taste. Proc. Natl. Acad. Sci. U.S.A. 99, 4692-4696.

Ozeck, M., Brust, P., Xu, H., and Servant, G. (2004) Receptors for bitter, sweet and umami taste couple to inhibitory G protein signaling pathways. Eur J Pharmacol. 489:139-149.

Pronin, A.N., Tang, H., Connor, J., and Keung, W. (2004). Identification of ligands for two human bitter T2R receptors. Chem Senses. 29:583-593.

Lu, M., Staszewski, L., Echeverri, F., Xu, H., and Moyer, B.D. (2004). Endoplasmic reticulum degradation impedes olfactory G-protein coupled receptor functional expression. BMC Cell Biol. 5:34-44

Lu, M., Echeverri, F., and Moyer, B.D. (2003) Endoplasmic reticulum retention, degradation, and aggregation of olfactory G-protein coupled receptors. Traffic, 4:416-433.

Zozulya, S., Echeverri, F., Nguyen, T. (2001) The human olfactory receptor repertoire. Genome Biol. 2:RESEARCH0018.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki